AnaptysBio Inc banner

AnaptysBio Inc
NASDAQ:ANAB

Watchlist Manager
AnaptysBio Inc Logo
AnaptysBio Inc
NASDAQ:ANAB
Watchlist
Price: 51.82 USD 1.71% Market Closed
Market Cap: $1.5B

During the last 3 months AnaptysBio Inc insiders have not bought any shares, and sold 1.3m USD worth of shares. The stock price has increased by 64% over this period (open performance analysis).

The last transaction was made on Mar 30, 2026 by Schmid John P. , who sold 701.7k USD worth of ANAB shares.

Last Transactions:
Schmid John P.
$-1.1m
Faga Daniel
$-28.9k
Loumeau Eric J
$-540k
Marquet Magda
$-447k
Lizzul Paul F.
$-163.2k
Faga Daniel
$-638.5k
Mulroy Dennis
$-112.4k
Loumeau Eric J
$-98.8k
Lizzul Paul F.
$-100.8k
Faga Daniel
$-415.1k
Mulroy Dennis
$-86.1k
Loumeau Eric J
$-91k
Loumeau Eric J
$-129k
Mulroy Dennis
$-145.5k
Faga Daniel
$-662.3k
Lizzul Paul F.
$-182.5k
Ware J. Anthony
$-193.3k
Lizzul Paul F.
$-75k
Mulroy Dennis
$-500k
Loumeau Eric J
$-510k
Loumeau Eric J
$-6.6k
Loumeau Eric J
$-460k
Loumeau Eric J
$-371k
Mulroy Dennis
$-417.8k
Loumeau Eric J
$-239k
Renton Hollings
$-60.5k
Renton Hollings
$-167.4k
Fenton Dennis M
$-72.3k
Renton Hollings
$-72.3k
Nodelman Oleg
$+86.1k
Nodelman Oleg
$+171.5k
Nodelman Oleg
$+842.1k
View All Transactions

During the last 3 months AnaptysBio Inc insiders have not bought any shares, and sold 1.3m USD worth of shares. The stock price has increased by 64% over this period (open performance analysis).

The last transaction was made on Mar 30, 2026 by Schmid John P. , who sold 701.7k USD worth of ANAB shares.

Sold
0-3
months
1.6m USD
3
3-6
months
5.8m USD
6
6-9
months
299.4k USD
2
9-12
months
311.9k USD
2
Bought
0-3
months
0
0 USD
3-6
months
0
0 USD
6-9
months
0
0 USD
9-12
months
0
0 USD

AnaptysBio Inc
Insider Trading Chart

AnaptysBio Inc
Insiders Performance

1 Week Later 1 Month Later 3 Months Later 6 Months Later 1 Year Later
Average Return
Median Return
Win Rate

AnaptysBio Inc
Last Insider Transactions

Global
Insiders Monitor

AnaptysBio Inc
Glance View

Market Cap
1.5B USD
Industry
Biotechnology

AnaptysBio, Inc. is a clinical stage biotechnology company. The company is headquartered in San Diego, California and currently employs 102 full-time employees. The company went IPO on 2017-01-26. The firm is focused on the immune control mechanisms applicable to inflammation and immuno-oncology indications. The company develops products using antibody discovery technology platform, which is based upon a natural process of antibody generation, known as somatic hypermutation, and replicates this natural process of antibody generation in vitro. Its advanced antibody programs include: Imsidolimab is an antibody that inhibits the interleukin-36 receptor, for the treatment of inflammatory diseases called generalized pustular psoriasis and hidradenitis suppurativa; Rosnilimab is an anti-PD-1 agonist antibody program, is designed to augment PD-1 signaling through Rosnilimab treatment to suppress T-cell driven human inflammatory diseases; anti-BTLA modulator antibody, known as ANB032, is applicable to human inflammatory diseases associated with lymphoid and myeloid immune cell dysregulation.

ANAB Intrinsic Value
45.72 USD
Overvaluation 12%
Intrinsic Value
Price $51.82

What is Insider Trading?

Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.

While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.

Why is Insider Trading Important?

It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.

However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.

Peter Lynch

Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett